Soleno Therapeutics, Inc.
Quick facts
Marketed products
- VYKAT XR · Electrolyte replacement / Internal Medicine
VYKAT XR is a sustained-release formulation of potassium that provides controlled delivery of potassium to treat hypokalemia.
Phase 3 pipeline
- Placebo for DCCR
This drug is a placebo for DCCR, meaning it has no active therapeutic effect.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: